Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Abate Kristin
Chief Accounting Officer at Karyopharm Therapeutics. Filing since 4 Mar 2025.
CIK 0002045943
Company
Date
Role
Action
Shares
Amount
Of holding
KPTI
Karyopharm Therapeutics Inc.
1 Oct 2026
Chief Accounting Officer
Sold at will
378
$449.82
1.6%
KPTI
Karyopharm Therapeutics Inc.
1 Sep 2026
Chief Accounting Officer
Sold at will
19
$38.38
0.1%
KPTI
Karyopharm Therapeutics Inc.
14 May 2026
Chief Accounting Officer
Sold at will
53
$503.50
0.2%
KPTI
Karyopharm Therapeutics Inc.
2 Mar 2026
Chief Accounting Officer
Sold at will
559
$5.26K
2.5%
KPTI
Karyopharm Therapeutics Inc.
28 Jan 2026
Chief Accounting Officer
Sold at will
50
$351.50
0.2%
KPTI
Karyopharm Therapeutics Inc.
21 Jan 2026
Chief Accounting Officer
Sold at will
265
$1.58K
1.2%
KPTI
Karyopharm Therapeutics Inc.
1 Oct 2025
Chief Accounting Officer
Sold at will
362
$2.28K
3.5%
KPTI
Karyopharm Therapeutics Inc.
15 Sep 2025
Chief Accounting Officer
Sold at will
23
$147.89
0.2%
KPTI
Karyopharm Therapeutics Inc.
3 Sep 2025
Chief Accounting Officer
Sold at will
12
$81.36
0.1%
KPTI
Karyopharm Therapeutics Inc.
22 Jul 2025
Chief Accounting Officer
Sold at will
238
$952.00
2.5%
KPTI
Karyopharm Therapeutics Inc.
4 Mar 2025
Chief Accounting Officer
Sold at will
571
$3.59K
5.6%
11 decisions on file.
